Skip to content

GRCE · Grace Therapeutics, Inc.

Healthcare · −3.1% on Oct 16

☆ Add to watchlist

Updated Oct 17 · 5 feeds behind: Insider filings, 2 days, and 4 more · Every feed →

On this page

The market view

Price chart

The interactive GRCE chart (by TradingView) loads here.

Our take

1 rule fired on GRCE

In short: none of these rules has solid or some evidence yet, so they show no clear lean on GRCE.

How each did in past tests, against similar stocks over 3 months. Past results don't predict future ones.

The 0–100 score for GRCE, and which of these rules are open on it right now
Members see one number for how strongly these rules agree on GRCE, and the day each rule fired. Better-tested rules count more, and so do different kinds of filings that point the same way.
See pricing →
Already a member? Sign in

Compare with this company’s history

Is disclosure activity unusual?

See how many different insiders or members of Congress reported purchases or sales of GRCE. Each bar covers 28 days, by disclosure date. Several trades by one person count once in each group and period.

Latest period: Sep 21, 2026–Oct 18, 2026 · UTC dates · today is excluded

Insider purchases

Short history

Only 1 earlier period is on file to compare with. We need at least 6 full periods before calling a count unusual.

Latest 28 days
1
Earlier median
2
Earlier range
2–2
Distinct filers per 28 daysScale: 0–2
Oct 20, 2025Oct 18, 2026
Earlier periodsLatest 28 daysEarlier median 2Limited or missing history

Who appears in the latest period?

Up to three filers; one example disclosure each.

Inspect this period’s filings

The history behind this view

First stored company disclosure: Aug 19, 2026. Newest disclosure across this feed: Oct 16, 2026.

Earlier periods in the comparison: 1. Outlined periods are missing data, so they are left out of the comparison. The chart scale changes with the category.

Exact counts, dates and filings for all four categories
Insider purchases · Short history

Only 1 earlier period is on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 2; range: 2–2.

Insider purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 2025—Unavailable
Nov 17, 2025–Dec 14, 2025—Unavailable
Dec 15, 2025–Jan 11, 2026—Unavailable
Jan 12, 2026–Feb 8, 2026—Unavailable
Feb 9, 2026–Mar 8, 2026—Unavailable
Mar 9, 2026–Apr 5, 2026—Unavailable
Apr 6, 2026–May 3, 2026—Unavailable
May 4, 2026–May 31, 2026—Unavailable
Jun 1, 2026–Jun 28, 2026—Unavailable
Jun 29, 2026–Jul 26, 2026—Unavailable
Jul 27, 2026–Aug 23, 20261Partial; excluded
Aug 24, 2026–Sep 20, 20262Within stored history
Sep 21, 2026–Oct 18, 2026Latest period1Within stored history
Insider sales · Short history

Only 1 earlier period is on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 0; range: 0–0.

Insider sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 2025—Unavailable
Nov 17, 2025–Dec 14, 2025—Unavailable
Dec 15, 2025–Jan 11, 2026—Unavailable
Jan 12, 2026–Feb 8, 2026—Unavailable
Feb 9, 2026–Mar 8, 2026—Unavailable
Mar 9, 2026–Apr 5, 2026—Unavailable
Apr 6, 2026–May 3, 2026—Unavailable
May 4, 2026–May 31, 2026—Unavailable
Jun 1, 2026–Jun 28, 2026—Unavailable
Jun 29, 2026–Jul 26, 2026—Unavailable
Jul 27, 2026–Aug 23, 20260Partial; excluded
Aug 24, 2026–Sep 20, 20260Within stored history
Sep 21, 2026–Oct 18, 2026Latest period0Within stored history
Congress purchases · History unavailable

No completed-period disclosures for this company are available in this source. Missing history is not zero activity. Earlier median: —; range: unavailable.

Congress purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 2025—Unavailable
Nov 17, 2025–Dec 14, 2025—Unavailable
Dec 15, 2025–Jan 11, 2026—Unavailable
Jan 12, 2026–Feb 8, 2026—Unavailable
Feb 9, 2026–Mar 8, 2026—Unavailable
Mar 9, 2026–Apr 5, 2026—Unavailable
Apr 6, 2026–May 3, 2026—Unavailable
May 4, 2026–May 31, 2026—Unavailable
Jun 1, 2026–Jun 28, 2026—Unavailable
Jun 29, 2026–Jul 26, 2026—Unavailable
Jul 27, 2026–Aug 23, 2026—Unavailable
Aug 24, 2026–Sep 20, 2026—Unavailable
Sep 21, 2026–Oct 18, 2026Latest period—Unavailable
Congress sales · History unavailable

No completed-period disclosures for this company are available in this source. Missing history is not zero activity. Earlier median: —; range: unavailable.

Congress sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 2025—Unavailable
Nov 17, 2025–Dec 14, 2025—Unavailable
Dec 15, 2025–Jan 11, 2026—Unavailable
Jan 12, 2026–Feb 8, 2026—Unavailable
Feb 9, 2026–Mar 8, 2026—Unavailable
Mar 9, 2026–Apr 5, 2026—Unavailable
Apr 6, 2026–May 3, 2026—Unavailable
May 4, 2026–May 31, 2026—Unavailable
Jun 1, 2026–Jun 28, 2026—Unavailable
Jun 29, 2026–Jul 26, 2026—Unavailable
Jul 27, 2026–Aug 23, 2026—Unavailable
Aug 24, 2026–Sep 20, 2026—Unavailable
Sep 21, 2026–Oct 18, 2026Latest period—Unavailable
How to read this comparison

The median is the middle count in up to 12 earlier, non-overlapping 28-day periods; the range runs from the smallest to the largest count. The latest period is excluded from both. A comparison needs at least 6 earlier periods, including 3 with activity. The feed’s latest disclosure must be within 7 days of the current period’s end. This freshness check does not verify complete collection.

Insiders include individuals and reporting entities; only purchase and sale codes enter this view. Congress counts reporting members, including their disclosed family transactions. The same filer can appear in purchases and sales, so these categories should not be added into a net count.

These are stored disclosures, not a complete measure of trading. Reporting delays and collection gaps can change the comparison. More activity does not identify a motive or predict a stock’s return.

Company timeline

What has been happening?

May 1, 2026–Oct 16, 2026. Select a month in a category to inspect its records.

Company filings

Insiders

Owners & lobbying

Insiders · Oct 2026

  1. Disclosed
    Opaleye Management Inc. · Purchase

    Transaction dated Oct 14, 2026

  2. Disclosed
    Opaleye Management Inc. · Purchase

    Transaction dated Oct 16, 2026

  3. Disclosed
    Opaleye Management Inc. · Purchase

    Transaction dated Oct 15, 2026

  4. Disclosed
    Opaleye Management Inc. · Purchase

    Transaction dated Oct 8, 2026

  5. Disclosed
    Opaleye Management Inc. · Purchase

    Transaction dated Oct 12, 2026

  6. Disclosed
    Opaleye Management Inc. · Purchase

    Transaction dated Oct 9, 2026

  7. Disclosed
    Opaleye Management Inc. · Purchase

    Transaction dated Oct 5, 2026

  8. Disclosed
    Opaleye Management Inc. · Purchase

    Transaction dated Oct 2, 2026

  9. Disclosed
    Opaleye Management Inc. · Purchase

    Transaction dated Oct 1, 2026

  10. Disclosed
    Opaleye Management Inc. · Purchase

    Transaction dated Sep 29, 2026

All 27 records in this snapshot
  1. Disclosed
    Opaleye Management Inc. · Purchase

    Transaction dated Oct 14, 2026

  2. Disclosed
    Opaleye Management Inc. · Purchase

    Transaction dated Oct 16, 2026

  3. Disclosed
    Opaleye Management Inc. · Purchase

    Transaction dated Oct 15, 2026

  4. Disclosed
    Opaleye Management Inc. · Purchase

    Transaction dated Oct 8, 2026

  5. Disclosed
    Opaleye Management Inc. · Purchase

    Transaction dated Oct 12, 2026

  6. Disclosed
    Opaleye Management Inc. · Purchase

    Transaction dated Oct 9, 2026

  7. Disclosed
    Opaleye Management Inc. · Purchase

    Transaction dated Oct 5, 2026

  8. Disclosed
    Opaleye Management Inc. · Purchase

    Transaction dated Oct 2, 2026

  9. Disclosed
    Opaleye Management Inc. · Purchase

    Transaction dated Oct 1, 2026

  10. Disclosed
    Opaleye Management Inc. · Purchase

    Transaction dated Sep 29, 2026

  11. Disclosed
    Opaleye Management Inc. · Purchase

    Transaction dated Sep 21, 2026

  12. Disclosed
    Opaleye Management Inc. · Purchase

    Transaction dated Sep 23, 2026

  13. Filed
  14. Disclosed
    Opaleye Management Inc. · Purchase

    Transaction dated Sep 9, 2026

  15. Disclosed
    Opaleye Management Inc. · Purchase

    Transaction dated Sep 8, 2026

  16. Disclosed
    Prashant Kohli · Purchase

    Transaction dated Sep 9, 2026

  17. Disclosed
    Opaleye Management Inc. · Purchase

    Transaction dated Aug 14, 2026

  18. Filed
  19. Record date
  20. Filed
  21. Filed
  22. Record date
  23. Record date
  24. Filed
  25. Record date
  26. Filed
  27. Record date

Month counts include every record on file. The lists show the newest records on this page. A dash means none on file that month. Trades use disclosure dates; contract dates follow the source record. Nearby events do not establish the cause of a price move.

Who's buying and selling · last 90 days

Congress

No Congress trades on GRCE disclosed in the last 90 days.

See every Congress trade on GRCE →

Company insiders

8 buys · 0 sells (16 filed lots) · $608K bought

  1. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$21.7Kdisclosed Oct 16 · filed 2 days after the trade
  2. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$68.8Kdisclosed Oct 16 · filed the same day
  3. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$45.7Kdisclosed Oct 16 · filed 1 day after the trade
  4. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$4.2Kdisclosed Oct 13 · filed 5 days after the trade · late
  5. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$14.6Kdisclosed Oct 13 · filed 1 day after the trade
  6. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$10.9Kdisclosed Oct 13 · filed 4 days after the trade
  7. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$3.5Kdisclosed Oct 5 · filed the same day
  8. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$41.4Kdisclosed Oct 5 · filed 3 days after the trade
  9. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$79Kdisclosed Oct 5 · filed 4 days after the trade
  10. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$16.4Kdisclosed Oct 1 · filed 2 days after the trade
See every insider trade on GRCE →

Big holders (Schedule 13D / 13G): 1 filing in the last 90 days · newest: Opaleye Management Inc. (13G), Aug 7, 2026 ↗

Filings & events

Company filings (8-K) 71

Events the company must report to the SEC within days — results, deals, departures, restatements.

What it files 8-Ks about

  • Other events · item 8.0115
  • Quarterly or yearly results · item 2.0212
  • Directors or officers joined, left or got new pay · item 5.024
  • Shareholder vote results · item 5.073
  • Signed a major agreement · item 1.012
  • Shared information with investors · item 7.011

Filing red flags 32

Warning signs in the company's own SEC filings — going-concern doubts, control weaknesses, staff comment letters, late filings, restatements, Wells notices, clinical holds, dividend cuts.

5% owners (13D / 13G) 2

Investors who reported owning 5% or more — 13D for owners who may push for changes, 13G for owners who just hold.

Push for changes, or just hold?

  • 13G, just holds: 2 filings

Filed by Opaleye Management Inc. · Nantahala Capital Management, LLC

Biggest named funds (13F)

The largest GRCE holdings among the well-known funds whose quarterly 13F filings we read — opens here.

Every disclosed trade on GRCE

  1. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$21.7Kdisclosed Oct 16 · filed 2 days after the trade
  2. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$68.8Kdisclosed Oct 16 · filed the same day
  3. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$45.7Kdisclosed Oct 16 · filed 1 day after the trade
  4. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$4.2Kdisclosed Oct 13 · filed 5 days after the trade · late
  5. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$14.6Kdisclosed Oct 13 · filed 1 day after the trade
  6. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$10.9Kdisclosed Oct 13 · filed 4 days after the trade
  7. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$3.5Kdisclosed Oct 5 · filed the same day
  8. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$41.4Kdisclosed Oct 5 · filed 3 days after the trade
  9. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$79Kdisclosed Oct 5 · filed 4 days after the trade
  10. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$16.4Kdisclosed Oct 1 · filed 2 days after the trade
  11. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$20.5Kdisclosed Sep 23 · filed 2 days after the trade
  12. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$11.2Kdisclosed Sep 23 · filed the same day
  13. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$12.2Kdisclosed Sep 10 · filed 1 day after the trade
  14. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$19.7Kdisclosed Sep 10 · filed 2 days after the trade
  15. ▲ BUYPrashant Kohli Chief Executive OfficerGRCE Grace Therapeutics, Inc.$214Kdisclosed Sep 10 · filed 1 day after the trade
  16. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$24.2Kdisclosed Aug 19 · filed 5 days after the trade · late
See the trades on GRCE in the feed →
People & votes

Which members of Congress traded GRCE, sponsored bills that touch it and voted on them — opens here.